Methods | Design: Prospective cohort Recruitment: Advertisments in local hospital in Catania, Italy Inclusion criteria: Healthy smokers 18 ‐ 60 years old, smoking ≥ 15 cpd for at least the past 10 years, and not wanting to quit smoking at any time in the next 30 days Exclusion criteria: History of alcohol and illicit drug use, psychiatric illness, recent myocardial infarction, angina pectoris, high blood pressure (BP > 140 mmHg systolic or 90 mmHg diastolic, or both), diabetes mellitus, severe allergies, poorly‐controlled asthma or other airways diseases |
|
Participants | Total N: 40, hospital staff 35% women, mean age 42.9 (SD 8.8), median cpd 25 (IQR 20 ‐ 30), median FTND 6.0 (IQR 6 ‐ 8) |
|
Interventions | Seen at baseline, given EC ('Categoria' brand) with an initial 4‐week supply of 7.4 mg nicotine cartridges. Instructed to use ad libitum up to 4 cartridges per day. EC cartridges supplied at months 1, 2, and 3 No instruction on cessation or reduction was provided |
|
Outcomes | Follow‐up at 1, 2, 3, 6, 18 and 24 months where cigarette consumption, CO, and AEs were measured, incl. 30‐day PP CO‐validated abstinence at 6 months and CO‐validated abstinence at 18 & 24 months (not otherwise defined) Adverse events |
|
Notes | Smoking cessation services provided to those who spontaneously asked for assistance with quitting. These participants were excluded from the study protocol | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | Prospective cohort |
Allocation concealment (selection bias) | High risk | Not randomized |
Blinding of participants and personnel (performance bias) All outcomes | High risk | No blinding |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Biochemical validation |
Incomplete outcome data (attrition bias) All outcomes | Low risk | 13/40 were lost to follow‐up, but used ITT analysis |
Selective reporting (reporting bias) | Unclear risk | Unable to determine prespecified outcomes |